Rare
lephants
Screener
Toggle theme
NeOnc Technologies Holdings, Inc.
NTHI
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
216.1%
216.1%
-348.2%
FY2025
355.0%
355.0%
-2,200.9%
Download CSV
